Vanguard Group
IMUX icon

Vanguard Group’s Immunic IMUX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.88M Buy
4,125,148
+193,600
+5% +$135K ﹤0.01% 3402
2025
Q1
$4.29M Buy
3,931,548
+7,785
+0.2% +$8.49K ﹤0.01% 3233
2024
Q4
$3.92M Sell
3,923,763
-776,253
-17% -$776K ﹤0.01% 3359
2024
Q3
$7.76M Buy
4,700,016
+959,969
+26% +$1.58M ﹤0.01% 3083
2024
Q2
$4.15M Buy
3,740,047
+346,000
+10% +$384K ﹤0.01% 3332
2024
Q1
$4.48M Buy
3,394,047
+1,703,047
+101% +$2.25M ﹤0.01% 3341
2023
Q4
$2.54M Buy
1,691,000
+28,411
+2% +$42.6K ﹤0.01% 3518
2023
Q3
$2.44M Sell
1,662,589
-13,685
-0.8% -$20.1K ﹤0.01% 3516
2023
Q2
$4.21M Buy
1,676,274
+170,600
+11% +$428K ﹤0.01% 3386
2023
Q1
$2.24M Buy
1,505,674
+434,254
+41% +$647K ﹤0.01% 3631
2022
Q4
$1.5M Buy
1,071,420
+76,749
+8% +$107K ﹤0.01% 3774
2022
Q3
$3.14M Buy
994,671
+115,649
+13% +$365K ﹤0.01% 3562
2022
Q2
$3.05M Sell
879,022
-77,675
-8% -$270K ﹤0.01% 3620
2022
Q1
$10.8M Buy
956,697
+54,867
+6% +$620K ﹤0.01% 3110
2021
Q4
$8.63M Buy
901,830
+20,625
+2% +$197K ﹤0.01% 3303
2021
Q3
$7.8M Buy
881,205
+169,432
+24% +$1.5M ﹤0.01% 3390
2021
Q2
$8.73M Sell
711,773
-20,127
-3% -$247K ﹤0.01% 3281
2021
Q1
$11.7M Buy
731,900
+48,537
+7% +$774K ﹤0.01% 3068
2020
Q4
$10.4M Buy
683,363
+33,157
+5% +$507K ﹤0.01% 2968
2020
Q3
$12.1M Buy
650,206
+402,278
+162% +$7.47M ﹤0.01% 2695
2020
Q2
$3.01M Buy
247,928
+236,408
+2,052% +$2.87M ﹤0.01% 3309
2020
Q1
$70K Hold
11,520
﹤0.01% 3980
2019
Q4
$112K Hold
11,520
﹤0.01% 3999
2019
Q3
$116K Sell
11,520
-3
-0% -$30 ﹤0.01% 4020
2019
Q2
$132K Sell
11,523
-561,429
-98% -$6.43M ﹤0.01% 4024
2019
Q1
$113K Sell
572,952
-119,970
-17% -$23.7K ﹤0.01% 4002
2018
Q4
$129K Sell
692,922
-788,986
-53% -$147K ﹤0.01% 3961
2018
Q3
$408K Buy
1,481,908
+148,016
+11% +$40.8K ﹤0.01% 3884
2018
Q2
$9.14M Buy
1,333,892
+158,672
+14% +$1.09M ﹤0.01% 2947
2018
Q1
$7.99M Buy
1,175,220
+76,755
+7% +$522K ﹤0.01% 2937
2017
Q4
$6.54M Buy
1,098,465
+181,604
+20% +$1.08M ﹤0.01% 3027
2017
Q3
$4.63M Buy
916,861
+178,340
+24% +$901K ﹤0.01% 3151
2017
Q2
$2.14M Sell
738,521
-107,337
-13% -$311K ﹤0.01% 3359
2017
Q1
$3.38M Buy
845,858
+13,654
+2% +$54.6K ﹤0.01% 3203
2016
Q4
$3.62M Buy
832,204
+49,803
+6% +$217K ﹤0.01% 3172
2016
Q3
$4.79M Buy
782,401
+4,592
+0.6% +$28.1K ﹤0.01% 3033
2016
Q2
$4.82M Buy
777,809
+14,645
+2% +$90.8K ﹤0.01% 3002
2016
Q1
$6.92M Buy
763,164
+56,105
+8% +$509K ﹤0.01% 2799
2015
Q4
$8.15M Buy
707,059
+140,961
+25% +$1.62M ﹤0.01% 2754
2015
Q3
$2.29M Buy
566,098
+134,396
+31% +$543K ﹤0.01% 3317
2015
Q2
$9.11M Buy
431,702
+32,945
+8% +$695K ﹤0.01% 2726
2015
Q1
$9.97M Buy
398,757
+33,221
+9% +$831K ﹤0.01% 2648
2014
Q4
$9.11M Buy
365,536
+266,138
+268% +$6.63M ﹤0.01% 2577
2014
Q3
$2.03M Buy
99,398
+54,264
+120% +$1.11M ﹤0.01% 3263
2014
Q2
$1.23M Buy
+45,134
New +$1.23M ﹤0.01% 3437